Rocketman,

We've been told that the FDA meetings will happen by year's end....they said nothing about this fall. Second, there is no guarantee that the meetings with the FDA will lead to FDA approving future BETonMACE study sites for US patients. Third, there's no proof that FDA approval of US study sites/patients will impact the share price. Please refrain from this type of speculation....it is borderline hyping (see rule 5 of Agoracom's 6 rules).

BearDownAZ